Compare OM & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OM | INCR |
|---|---|---|
| Founded | 2003 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.2M | 58.6M |
| IPO Year | 2020 | 2021 |
| Metric | OM | INCR |
|---|---|---|
| Price | $2.82 | $3.28 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 82.8K | 9.8K |
| Earning Date | 11-04-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $119,476,000.00 | N/A |
| Revenue This Year | $6.72 | $222.95 |
| Revenue Next Year | $9.25 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.09 | N/A |
| 52 Week Low | $2.84 | $0.68 |
| 52 Week High | $6.49 | $6.10 |
| Indicator | OM | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 27.40 | 32.01 |
| Support Level | N/A | $3.12 |
| Resistance Level | $3.31 | $4.19 |
| Average True Range (ATR) | 0.30 | 0.25 |
| MACD | -0.16 | -0.01 |
| Stochastic Oscillator | 3.47 | 15.00 |
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.